Navigation Links
Results from Abbott's PROSPECT Study Provide New Insight into Role of Vulnerable Plaque in Coronary Artery Disease
Date:9/24/2009

SAN FRANCISCO, Sept. 24 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced primary results from its groundbreaking PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) clinical trial. PROSPECT is the first prospective natural history study to evaluate the role of vulnerable plaque in unexpected heart attacks and the natural progression of coronary artery disease. Results were presented today during the late-breaking clinical trials session by Gregg W. Stone, M.D., professor of medicine at Columbia University Medical Center, during the 2009 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting.

"We know that certain vulnerable plaques lead to sudden cardiac death, but until now, our understanding of how these plaques progress has been extremely limited," said Dr. Stone, who is also immediate past chairman of the Cardiovascular Research Foundation, New York, and principal investigator of the PROSPECT study. "PROSPECT has provided fundamental insights into our understanding of atherosclerosis. Conventional wisdom has been that if we could identify vulnerable plaques, we would be able to determine who might be at risk for a serious cardiac event and treat them prophylactically."

Vulnerable plaques are inflamed, lipid-rich lesions that form in the walls of the arteries and usually have thin, fibrous caps. The relationship between vulnerable plaque ruptures and sudden cardiac death is well known, but until the PROSPECT study, no systematic effort had been made to prospectively understand the event rate associated with progression of vulnerable plaque. Unlike hardened plaque, vulnerable plaques are often not visible with angiography and do not actually block blood flo
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Research and Markets  has announced the addition ... 2014-2017" report to their offering. ... protein drug market has been expanding rapidly owing to ... like. During 2005-2013, sales of recombinant protein drugs available ... 19.1%, and it is projected that ...
(Date:11/21/2014)... CORONA, Calif. and VIENNA, Va. ... an innovative in-home care provider that operates in ... with BeClose, a leading provider of remote caregiving technology. Alta ... new and existing client receiving homecare services. ... believe this technology is the key to providing the ...
(Date:11/21/2014)... , Nov. 21, 2014  World Hemp Oil, an ... THC, announces they are now offering legal, organic oil ... Web type strains grown in medical marijuana states. People ... disorders, such as Parkinson,s, MS, and spinal cord injury, ... to pass, because imported CBD Oil Is legal in ...
Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3
... N.J., Dec. 9, 2011  Saint-Gobain Performance Plastics has upgraded ... new state-of-the art laser engraving system. The system ... or tag of all hose assemblies, piping and ... Saint-Gobain Performance Plastics can engrave crimp collars on ...
... 2011 Gen-Probe Incorporated (NASDAQ: GPRO ) announced today ... Conference in New York on December 14, 2011 at approximately 10:15 ... and may be accessed through a link on the investors section ... available for 30 days following the event. ...
Cached Medicine Technology:Saint-Gobain Introduces Laser Engraving for Hose Assemblies 2Gen-Probe to Webcast Presentation at the Oppenheimer 22nd Annual Healthcare Conference 2
(Date:11/24/2014)... 24, 2014 Mental health issues ... They break up families, ruin careers, and generally ... for those that suffer,” says Hardy Nutritionals® ... showing that our specialized nutritional treatments can reverse ... on “Mind Over Matter”, the premiere episode of ...
(Date:11/24/2014)... (PRWEB) November 24, 2014 Dr. Michael ... Fertility Center, recently appeared on NBC to discuss egg freezing ... freezing has been trending in the news recently, with new ... procedure for women. , “[The companies] see it ... are on a career hot path.” Says Dr. Kettel. , ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 The ... Market 2006 to 2020 - Asia-Pacific” provides quantitative ... devices market segments: minimally invasive body contouring devices, ... The analysis includes market size data by revenue ... the following countries: China, Japan, South Korea, Australia ...
(Date:11/23/2014)... (HealthDay News) -- The holidays can be a challenge ... can trigger major meltdowns, an expert says. "Holidays ... circumstances, but when you have children with special needs, ... therapy professor at University of the Sciences in Philadelphia, ... to let your hosts or visitors know what special ...
(Date:11/23/2014)... York, NY (PRWEB) November 23, 2014 ... the past month in a federal litigation involving Byetta ... similar diabetes medications, Bernstein Liebhard LLP reports. , ... 566 claims over a class of Type 2 diabetes ... filed in the U.S. District Court, Southern District of ...
Breaking Medicine News(10 mins):Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4
... PHILADELPHIA, Dec. 24 Congressman Chaka Fattah (D-PA) releases the ... reform legislation: , "Senate Democrats deserve our thanks and ... to do, but I am confident that the House and ... the new year we will be sending President Obama a ...
... Today, The U.S. Conference of Mayors (USCM) congratulates the U.S. Senate ... millions of the uninsured. In a historic Christmas Eve session, ... Protection and Affordable Care Act. , "Not since 1963, has ... It is appropriate the most important piece of health ...
... cells generate embryonic-like cells, study finds , THURSDAY, Dec. 24 ... fight the common cold and heal wounds, but the antioxidant ... generate embryonic-like stem cells, new research suggests. , The ... Stem Cell , add to previous research that showed how ...
... , WASHINGTON, Dec. 24 "The Senate,s historic vote ... creation of a transformational national long-term services and supports insurance ... people with disabilities. The Senate bill also includes means by ... acute and long-term problems. It will stimulate innovation in ...
... , , WASHINGTON, Dec. ... critical that this step be accomplished as we continue our journey ... committed to working with Congress to ensure health insurance reform is ... Delgado, President and CEO of the National Alliance for Hispanic Health, ...
... of the Bipartisan Policy Center Report Continue to Encourage Joint ... U.S. Senate Majority Leaders Howard Baker, Tom Daschle and Bob ... and Leaders, Project on the State of American Health Care, ... and Affordable Care Act of 2009 today. , ...
Cached Medicine News:Health News:Senate Action Part of Long Road to Health Care Reform 2Health News:Former Senate Majority Leaders Baker, Daschle and Dole Commend Senate Passage of Health Care Bill 2Health News:Former Senate Majority Leaders Baker, Daschle and Dole Commend Senate Passage of Health Care Bill 3
Inquire...
Inquire...
Inquire...
... a range of 18 Ophthalmic frames ... and producted to the very hightest ... super lightweight Titanium and Beta Titanium ... host of beautifully formed and innovative ...
Medicine Products: